Amerika Birleşik Devletleri Sağlık Çalışanlarında Tüberküloz Tarama, Test ve Tedavisi: Ulusal Tüberküloz Kontrol Merkezi ve CDC Önerileri, 2019

Özet

1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54(No. RR-17):1-141. 2. Briss PA, Zaza S, Pappaioanou M, Fielding J, Wright-De Agüero L, Truman BI. Developing an evidence-based guide to community preventive servicesmethods. Am J Prev Med 2000;18(1 Suppl):35-43. 3. Zaza S, Wright-De Agüero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH. Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Am J Prev Med 2000;18(Suppl):44-74. 4. CDC. Reported tuberculosis in the United States, 2016. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc. gov/tb/statistics/reports/2016/pdfs/2016_Surveillance_FullReport.pdf 5. Stewart RJ, Tsang CA, Pratt RH, Price SF, Langer AJ. Tuberculosis-United States, 2017. MMWR Morb Mortal Wkly Rep 2018;67:317-23. 6. Lambert LA, Pratt RH, Armstrong LR, Haddad MB. Tuberculosis among healthcare workers, United States, 1995-2007. Infect Control Hosp Epidemiol 2012;33:1126-31. 7. Mullie GA, Schwartzman K, Zwerling A, N’Diaye DS. Revisiting annual screening for latent tuberculosis infection in healthcare workers: a costeffectiveness analysis. BMC Med 2017;15:104. 8. Dobler CC, Farah WH, Alsawas M, Mohammed K, Breeher LE, Murad MH, et al. Tuberculin skin test conversions and occupational exposure risk in US healthcare workers. Clin Infect Dis 2018;66:706-11. 9. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:62-70. 10. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, et al.; fort he Tuberculosis Epidemiologic Studies Consortium. Interferon-g release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014;189:77-87. 11. World Health Organization. Framework towards tuberculosis elimination in low-incidence countries: methods. Geneva, Switzerland: World Health Organization; 2014. https://www.ncbi.nlm.nih.gov/books/NBK254259/ 12. The World Bank. World Bank country and lending groups. Washington, DC: The World Bank; 2019. https://datahelpdesk.worldbank.org/ knowledgebase/articles/906519 13. CDC. Advisory Committee for the Elimination of Tuberculosis record of the proceedings: April 17, 2018. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/maso/facm/pdfs/acet/ FINAL508cACETMinutesApril172018.pdf 14. CDC. Health Infection Control Practices Advisory Committee record of the proceedings: May 17- 18, 2018. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/hicpac/pdf/2018-MayHICPAC-Summary-508.pdf 15. National Tuberculosis Controllers Association; California Tuberculosis Controllers Association. National tuberculosis conference agenda. Palm Springs, CA; May 21-24, 2018. http://www.tbcontrollers.org/docs/ conference/2018/NTC_Conference2018_Agenda_final.pdf 16. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017;64:111-5. 17. CDC. Treatment regimens for latent TB infection (LTBI). Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc. gov/tb/topic/treatment/ltbi.htm 18. LoBue PA, Mermin JH. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA. Lancet Infect Dis 2017;17:e327-e333.